Table 2.

Baseline cardiopulmonary patient profiles (N=10).

Patient number	Cardiac diagnosis	LVEFa (%)	Pulmonary diagnosis	DLCOb
1	HFpEFc	63	COPDd GOLDe IV, group A	43
2	HFrEFf	35	COPD GOLD IV, group D	40
3	HFmrEFg	47	COPD GOLD II, group B	53
4	HFpEF	53	COPD GOLD IV, group D; recent COVID-19 infection	25
5	HFpEF	60	Asthma, bronchiectasis	—h
6	HFpEF	63	COPD GOLD II, group D	29
7	HFrEF	35	Asthma, unilateral emphysema	50
8	HFmrEF	40	COPD GOLD IV, group D	31
9	HFrEF	35	COPD GOLD II, group B; recent COVID-19 infection	68
10	HFpEF	65	COPD GOLD IV, group D	26

^aLVEF: left ventricular ejection fraction.

^bDLCO: diffusing capacity for carbon monoxide.

^cHFpEF: heart failure with preserved ejection fraction.

^dCOPD: chronic obstructive pulmonary disease.

^eGOLD: Global Initiative for Chronic Obstructive Lung Disease.

^fHFrEF: heart failure with reduced ejection fraction.

^gHFmrEF: heart failure with midrange ejection fraction.

^hNot available.